3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
36
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Burkitt Lymphoma
11
Recurrence
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Neoplasms, Plasma Cell
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Plasma Cell
1
Interventions
Injections
8
pembrolizumab
4
Pemetrexed
4
Carboplatin
4
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
trifluridine tipiracil drug combination
2
sotorasib
2
fludarabine
2
Paclitaxel
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
zimberelimab
1
trametinib
1
toripalimab
1
tislelizumab
1
sacituzumab govitecan
1
palbociclib
1
netrin-1 inhibitor NP137
1
cemiplimab
1
WW Domain-Containing Oxidoreductase
1
SYS6006 COVID-19 vaccine
1
Panitumumab
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Fulvestrant
1
Etoposide
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
Calcium Dobesilate
×
90 days
×
Clear all
No trials found.